Food-borne infections are among the prominent health hazards. Antibacterial agents (ABA) are usually administered to poultry in Lebanon as antibiotic growth promoters (AGP), which might lead to the dissemination of resistant bacterial strains. e aims of this study were to isolate potential food borne pathogens from poultry and investigate an association between AGP usage and antibacterial resistance (ABR). Isolates were obtained from the culture of cloacae swabs and identified. Escherichia coli was the predominant isolate. ere was a significant association between the use of tetracycline and gentamicin as AGP and the number of E. coli isolates resistant to these ABA.
e abuse or misuse of antibacterial agents (ABA) as growth promoters (AGP) for livestock is of major concern in Lebanon and other developing countries. Antibacterial resistance (ABR) of enteric bacteria isolated from poultry attracts attention due to its direct in uence on public health, through elevating the morbidity, mortality, and treatment costs of infectious diseases caused by cross-resistance to drugs used in human medicine (Warren et al., 2008) . Increased exposure of intestinal bacterial ora to ABA which is administered for disease prophylaxis, treatment, and growth promotion is one of the causes for the emergence of resistant strains (Gyles, 2008) .
ABA have been used intensively in poultry farming since 1950's, with blurry figures representing the annual administered amounts for "non-therapeutic use", namely disease prevention and growth promotion, ranging from 27.3 million to 16 million pounds of ABA in USA at 2001, according to the Union of Concerned Scientists and the Institute of Medicine respectively (Shea, 2003) .
Taking into consideration the recommendations of the Swann report (Swann Report, 1969) and WHO report (WHO, 1997) to phase out the use of ABA as AGP many European countries cut down the non-therapeutic use of ABA. On January 1, 2006, the European Union (EU) abandoned the use of AGP in feed for livestock (Regulation EC No. 1831 /2003 . Fruitful results were re ected in decreased ABR in zoonotic bacteria without loss of food productivity (Aarestrup et al., 2001; Phillips et al., 2004) .
On the other hand, many countries, including Lebanon, continue to use AGP in food production (Bywater and Casewell, 2000; Phillips et al., 2004) . It is noteworthy to mention that recently in the United States, during the 111 th Congress, a legislation entitled: the Preservation of Antibiotics for Medical Treatment Act of 2009 (H.R. 1549; S. 619) was introduced to restrict the non-therapeutic use in livestock and poultry of "critical antimicrobial animal drugs" such as penicillin, tetracycline, macrolide, aminoglycosides, and sulfonamides.
is controversial legislation was supported by some federal agency officials and was opposed by most U.S. livestock and poultry producers, driven by concerns about animal welfare, food safety, and possible increases in production costs (Johnson, 2010 AGP used to the resistance patterns. e results might alert the public health authorities to take the necessary measures to control the use of AGP in animal feeds. During a 2-month period, 111 cloacae swabs were collected from six layer farms. Four of six layer farms used AGP (farms A, B, C and D). e average age of layers was 9.2 ± 7.7 months. A questionnaire was used to record name of farm (A to F), location, breed/strain, age of birds and AGP administered (Table I) .
Sterile cotton swabs were used to take specimens from live chickens. e cloacae swabs were placed in tryptic soy broth at room temperature. Prior approval by the Animal Care Committee was obtained.
Only isolation of Gram-negative rods, excluding Salmonella species, was attempted. All broth cultures were sub-cultured on MacConkey agar plates (BBL, Becton Dickinson Microbiology Systems, Cockeysville, MD) and the most dominant characteristic colony was selected and sub-cultured on MacConkey agar plates. e final pure culture was identified using the API 20E kit (BioMerieux, Paris, France). A number of species were identified from 111 isolates (Table II) , and some of them such as E. coli, K. pneumoniae, P. aeruginosa and Enterobacter cloacae, are causes of various human infections, such as pneumonia, meningitis and urinary tract infections (Moniri and Dastehgoli, 2005, Warren et al., 2008; Harajly et al., 2010) . Two of the isolates, Hafnia alvei and Pseudomonas putida are not human pathogens but it is worth noting that the latter bacterium is the only patented living organism. Its discoverer reported that it degrades oils (Connors et al., 1997; Van Beilen and Funho , 2007) .
Antimicrobial susceptibility testing using the KirbyBauer disk di usion method following the Clinical and Laboratory Standards Institute, CLSI (CLSI ,2006) guidelines was performed.
Bacterial inoculums were streaked on a MuellerHinton II agar plate (BBL, Becton Dickinson Microbiology Systems, Cockeysville, MD) to obtain con uent growth. All isolates were tested for six antimicrobial agents (Oxoid, Basingstoke, UK): amoxicillin/ clavulanic acid (30 µg ml ), and sulfamethoxazole/ trimethoprim (SXT) (25 µg ml -1 ). Selection of ABAs tested was based primarily on antibacterial agents that were used as a food additive.
e majority of isolates were resistant to tetracycline (76 isolates; 68.5%) followed by SXT (49 isolates; 44.1%), cipro oxacin/enro oxacin (34 isolates; 30.6%), gentamicin (26 isolates; 23.4%) and amoxicillin/clavulanic acid (11 isolates; 9.9%). Only 1 isolate was resistant to ce riaxone (0.9%) ( Table II) .
E. coli isolates were used to investigate a link between ABA administration and ABR patterns because they were the predominant isolates obtained (82 of 111 isolates) and E. coli is used as an indicator of food and water contamination (Angulo et al., 2004) .
Relative Risk (RR) and 95% Confidence Interval (CI) were determined to see if an ABA administered as a AGP was associated with the number of E. coli isolates resistant to the ABA in a statistically significant manner. RR and CI were determined by the method described by Hutchon, DJR (Hutchon, 1999 ). An RR more than one and a CI that does not include the number "1" indicated significance.
Tetracycline was used as an AGP in 3 of 6 and gentamicin in 2 of 6 layer farms. ere was a significant Abbreviations: AGP = Antibiotic Growth Promoter; AMC: amoxicillin/clavulanic acid; GN: gentamicin; TE: tetracycline; CIP: cipro oxacin; SXT: sulphamethaxazole/trimethoprim; CRO: ce riaxone; ND: not done; N: number of E. coli isolates; -: no AMA was administered as AGP. AUB; American University of Beirut. Total number of layers (Farms A, B, C, D, E and F) = 103,000. e average age of layers was 9.2 ± 7.7 months. association between tetracycline or gentamicin used as an AGP and the number of resistant E. coli isolates to these ABA (RR for Tetracycline = 19.1, 95% CI = 2.8 to 130.3. RR for Gentamicin = 4.2, 95% CI = 2.5 to 6.9) (Table III) .
On the other end, there were no or few isolates that were resistant to an ABA that was not used as a AGP. None of the layer farms administered ce riaxone or amoxacillin/clavulonic acid as an AGP and none of the isolates were resistant to ce riaxone while only 3 of 82 E. coli isolates were resistant to amoxacillin/ clavulonic acid.
Interestingly, 32 of 82 (39%) E. coli isolates from farms that did not use cipro oxacin (a quinolone) as an AGP and 38 of 68 (56%) isolates from farms that did not use SXT as an AGP were resistant to these ABAs. Cross resistance with other ABAs that block bacterial porins and/or modify bacterial in ux/e ux pumps, thus preventing the assimilation of SXT and ciprooxacin to their intracellular targets, might be involved (Boerlin and Reid-Smith, 2008; Warren et al., 2008) .
Deciphering the intricacies of bacterial resistance against SXT has been a controversial issue. In our study, no significant association existed between the use of SXT as an AGP and the number of resistant isolates to this ABA (RR = 0). Our findings indicate that in farms not using SXT as an AGP, 38 of 68 (56%) isolates were resistant. Moreover, in farm D where SXT was used as an AGP, none of the E. coli isolates from these birds were resistant to SXT (Table I) . It therefore appears that Number of isolates resistant to AGP Number of isolates susceptible to AGP abuse or misuse of SXT is not the only factor involved in the development of resistance, warm climates and poor hygiene may play a role (Lester et al., 1990) . Moreover, Huovinen et al. (1995) reported that E. coli isolates in developing countries were more resistant to SXT than those from developed countries. It may be argued that E. coli isolated from older birds are longer exposed to ABAs and are more likely to develop resistance to ABAs than isolates from younger birds. Referring to Table I , the number of resistant isolates from birds did not appear to correlate with the age of the birds.
e dissemination of resistant strains is of concern since the Lebanese ministry of agriculture permits the use AGP in poultry farming and estimates that Lebanon produces 144,023 tons of poultry food products, exports 894 tons of its local production of poultry food products, and the consumption per person of poultry meat in 2007 was 24.3 kg (Ministry of Agriculture, 2007) .
In conclusion, ABR epidemiology is sparked by the concern of transmitting drug resistant food borne patho gens to humans, either through food supply or direct contact with animals, contributing to human illnesses with elevated rates of treatment failures. Our findings suggest a relationship between ABA administration and emergence of ABR of E. coli isolates obtained from the normal ora of layers, arising fears of consequent dissemination of resistant bacteria to humans and urging the need to reevaluation and change in practice. Abolishing the use of AGP alone is not enough (Van Den Bogaard et al., 2000) if uncoupled with prudent ABA therapeutic usage, eradication programs for specific pathogens, and ABR surveillance programs coordinating their e orts on the national, continental, and international level to maintain an achievable high quality of food and health.
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